Publications by authors named "Andrew Motlis"

Claim this Profile
T
Two year follow-up of Crohn's patients substituted to certolizumab anti-TNFa therapy: SAVANT 2.
Andrew Motlis, Moheb Boktor, Paul Jordan, Urska Cvek, Marjan Trutschl

Pathophysiology· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substitution with Alternative Anti-TNFα Therapy (SAVANT)-Outcomes of a Crohn's Disease Cohort Undergoing Substitution Therapy with Certolizumab.
Moheb Boktor, Andrew Motlis, Avinash Aravantagi, Ankur Sheth, Paul Jordan

Inflamm Bowel Dis· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis